期刊
PLOS ONE
卷 7, 期 3, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0033582
关键词
-
资金
- National Institutes of Health, Bethesda, Maryland [E Y017347, EY019506, EY03040, EY06044]
- Research to Prevent Blindness, Inc., New York, New York
The small heat shock protein, alpha A-crystallin null (alpha A(-/-)) mice are known to be more prone to retinal degeneration than the wild type mice in Experimental Autoimmune Uveoretinitis (EAU). In this report we demonstrate that intravenous administration of alpha A preserves retinal architecture and prevents photoreceptor damage in EAU. Interestingly, only alpha A and not alpha B-crystallin (alpha B), a closely related small heat shock protein works, pointing to molecular specificity in the observed retinal protection. The possible involvement of alpha A in retinal protection through immune modulation is corroborated by adaptive transfer experiments, (employing alpha A(-/-) and wild type mice with EAU as donors and Rag2(-/-) as the recipient mice), which indicate that alpha A protects against the autoimmune challenge by modulating the systemic B and T cell immunity. We show that alpha A administration causes marked reduction in Th1 cytokines (TNF-alpha, IL-12 and IFN-gamma), both in the retina and in the spleen; notably, IL-17 was only reduced in the retina suggesting local intervention. Importantly, expression of Toll-like receptors and their associated adaptors is also inhibited suggesting that alpha A protection, against photoreceptor loss in EAU, is associated with systemic suppression of both the adaptive and innate immune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据